Protein modification, bioconjugation, and disulfide bridging using bromomaleimides

Journal of the American Chemical Society

Volumn 132, Issue 6, 2010, Pages 1960-1965

  Smith, Mark E B ^a   Schumacher, Felix F ^a   Ryan, Chris P ^a   Tedaldi, Lauren M ^a   Papaioannou, Danai ^b   Waksman, Gabriel ^b   Caddick, Stephen ^a   Baker, James R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEINS; BIO-CONJUGATION; CYSTEINE RESIDUES; DISULFIDE BONDS; MALEIMIDES; NEW OPPORTUNITIES; PEPTIDE HORMONES; PROTEIN MODIFICATIONS; SH2 DOMAIN;

PEPTIDES; PHOSPHORUS COMPOUNDS;

CHEMICAL MODIFICATION;

BROMOMALEIMIDE; CYSTEINE; DIBROMOMALEIMIDE; FLUORESCEIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MALEIMIDE DERIVATIVE; PHOSPHINE; PROTEIN SH2; SOMATOSTATIN; THIOL; UNCLASSIFIED DRUG;

ARTICLE; CONJUGATION; DISULFIDE BOND; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS;

AMINO ACID SEQUENCE; CYSTEINE; DISULFIDES; GRB2 ADAPTOR PROTEIN; MALEIMIDES; MODELS, MOLECULAR; SOMATOSTATIN; SRC HOMOLOGY DOMAINS;

EID: 77249100285     PISSN: 00027863     EISSN: 15205126     Source Type: Journal    
DOI: 10.1021/ja908610s     Document Type: Article

References (19)

1. Lundblad, R. L. Chemical Reagents for Protein Modification, 3rd ed.; CRC Press: Boca Raton, FL, 2005.
2. Chalker, J. M.; Bernardes, G. J. L.; Lin, Y. A.; Davis, B. G. Chem. Asian J. 2009, 4, 630-640.
3. Fodje, M. N.; Al-Karadaghi, S. Protein Eng. 2002, 15, 353-358.
4. Hermanson, G. T. Bioconjugate Techniques; Academic Press: London, 1996.
5. Schelte, P.; Boeckler, C.; Frisch, B.; Schuber, F. Bioconjugate Chem. 2000, 11, 118-123.
6. Vanderhooft, J. L.; Mann, B. K.; Prestwich, G. D. Biomacromolecules 2007, 8, 2883-2889.
7. Gregory, J. D. J. Am. Chem. Soc. 1955, 77, 3922-3923.
8. Bednar, R. A. Biochemistry 1990, 29, 3684-3690.
9. Saito, G.; Swanson, J. A.; Lee, K. D. Adv. Drug Deliver. Rev. 2003, 55, 199-215.
10. Baker, J. R.; Tedaldi, L. M.; Smith, M. E. B.; Nathani, R. Chem. Comm. 2009, 6583-6585.
11. Schafer, F. Q.; Buettner, G. R. Free Radic. Biol. Med. 2001, 30, 1191-1212.
12. Balan, S.; Choi, J. W.; Godwin, A.; Teo, I.; Laborde, C. M.; Heidelberger, S.; Zloh, M.; Shaunak, S.; Brocchini, S. Bioconjugate Chem. 2007, 18, 61-76.
13. Brocchini, S.; Godwin, A.; Balan, S.; Choi, J. W.; Zloh, M.; Shaunak, S. Adv. Drug Delivery Rev. 2008, 60, 3-12.
14. Shaunak, S.; Godwin, A.; Choi, J. W.; Balan, S.; Pedone, E.; Vijayarangam, D.; Heidelberger, S.; Teo, I.; Zloh, M.; Brocchini, S. Nat. Chem. Biol. 2006, 2, 312-313.
15. Freda, P. U. J. Clin. Endocrinol. Metab. 2002, 87, 3013-3018.
16. Oberg, K. Expert Rev. Anticancer Ther. 2009, 9, 557-566.
17. Dubernet, M.; Caubert, V.; Guillard, J.; Viaud-Massuard, M. C. Tetrahedron 2005, 61, 4585-4593.
18. Munkholm, C.; Parkinson, D. R.; Walt, D. R. J. Am. Chem. Soc. 1990, 112, 2608-2612.
19. Baker, J. R.; Caddick, S.; Smith, M. E. B. Patent applications 0913965.0 (reversible covalent linkage of functional moities), 0913967.6 (functionalization of solid substrates), and 0914321.5 (thiol protecting group), August 2009.